Renal Cell Carcinoma
Reports outline renal cell carcinoma study findings from University of Strasbourg
Published in Gene Therapy Weekly, February 21st, 2008
"We evaluated whether targeting NF-kappa B could be of therapeutic and prognostic values in human RCC. The activation of the NF-kappa B pathway in human RCC cells and tumors was investigated by Western blot. In vitro, the effects of BAY 117085 and sulfasalazine, two NF-kappa B inhibitors, on tumor cell growth were investigated by cell counting, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide analysis, terminal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2008-02-21)
More Articles from Gene Therapy Weekly
- Breast Cancer
Unsuspected protein determines resistance to breast cancer treatment - Gene Therapy
Debate over safety of gene therapy trials focuses on issue of informed consent - Bird Flu
New Vaccine Against Deadliest Strain of Avian Flu Tested by University of Pittsburgh Scientists - Bone Research
New bone research study findings have been reported from University of Quebec - Breast Cancer
Reports summarize breast cancer study results from Columbus Children's Hospital - Breast Cancer
Research from M.D.L. Santos and colleagues has provided new data on breast cancer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
